3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Testicular Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Adrenal Gland Neoplasms
2
Vaginal Neoplasms
1
Uterine Neoplasms
1
Thymus Neoplasms
1
Solitary Fibrous Tumors
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Penile Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Neoplasms, Unknown Primary
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Interventions
Gemcitabine
11
Cisplatin
10
pembrolizumab
5
Oxaliplatin
4
durvalumab
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Fluorouracil
3
tivozanib
2
Specimen Handling
2
Capecitabine
2
zimberelimab
1
trametinib
1
tislelizumab
1
quemliclustat
1
pertuzumab
1
olaparib
1
irinotecan sucrosofate
1
atezolizumab
1
anlotinib
1
Yttrium-90
1
Tissue Adhesives
1
Tegafur
1
Stents
1
S 1 (combination)
1
Ritonavir
1
Radiosurgery
1
Pancreaticojejunostomy
1
Pancreaticoduodenectomy
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bile Duct Neoplasms
×
FAPI-46
×
1 year
×
Clear all
No trials found.